Clinical Approach to Palpitations
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of palpitations
Palpitations are one of the most common cardiovascular complaints encountered in primary care, accounting for approximately 16% of all symptoms reported to general practitioners and representing the second most common reason for cardiology referral after chest pain. Studies estimate that palpitations affect up to 25% of the general population at some point in their lives, with a higher prevalence in women. While the majority of cases have benign etiologies, approximately 15-20% are caused by cardiac arrhythmias, and up to 35% of patients with palpitations are found to have an underlying psychiatric disorder such as anxiety or panic disorder.
Definition
Palpitations are defined as an unpleasant awareness of the heartbeat, often described as a sensation of the heart racing, pounding, fluttering, skipping beats, or beating irregularly. This subjective symptom represents a heightened perception of cardiac activity that may or may not correlate with an actual cardiac rhythm disturbance. Importantly, palpitations are a symptom, not a diagnosis, and their presence does not necessarily indicate cardiac pathology.
Key Epidemiological Facts
- Accounts for approximately 16% of symptoms reported to primary care physicians
- Second most common reason for cardiology referral (after chest pain)
- 40-50% of patients with palpitations have cardiac arrhythmias on monitoring
- Only 10-15% have clinically significant arrhythmias requiring treatment
- Up to 35% have associated psychiatric disorders (anxiety, panic, depression)
- Higher prevalence in women and patients with pre-existing heart disease
Classification by Duration and Frequency
| Category | Duration/Pattern | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute/Episodic | Seconds to minutes; isolated episodes | Premature beats (atrial or ventricular), paroxysmal supraventricular tachycardia, anxiety, caffeine | Often benign; evaluate for triggers and underlying substrate |
| Paroxysmal | Recurrent episodes with sudden onset and termination | Paroxysmal supraventricular tachycardia, paroxysmal atrial fibrillation, ventricular tachycardia | Suggests re-entrant or focal arrhythmia mechanism; may require electrophysiology study |
| Persistent | Continuous for hours to days | Sustained atrial fibrillation, atrial flutter, thyrotoxicosis | Higher risk of hemodynamic compromise; requires rhythm or rate control |
| Chronic/Recurrent | Repeated episodes over weeks to months | Frequent ectopy, chronic atrial fibrillation, anxiety disorder, structural heart disease | Requires systematic workup; quality of life impact assessment needed |
Classification by Character
Racing or Rapid Heartbeat
Description: Sensation of the heart beating very fast, often with regular rhythm
Suggests: Sinus tachycardia, supraventricular tachycardia, atrial flutter with fixed conduction, ventricular tachycardia
Key question: “Does it start and stop suddenly, or gradually speed up and slow down?”
Skipping or Missed Beats
Description: Sensation of the heart pausing or missing a beat, often followed by a stronger beat
Suggests: Premature atrial contractions, premature ventricular contractions
Key question: “Do you feel a pause followed by a thump or strong beat?”
Pounding or Forceful Beats
Description: Awareness of unusually strong heartbeats, often at normal rate
Suggests: Hyperdynamic states (anxiety, anemia, hyperthyroidism), aortic regurgitation, hypertension
Key question: “Is the heart beating hard but not necessarily fast?”
Fluttering or Irregular Beats
Description: Sensation of chaotic or completely irregular rhythm
Suggests: Atrial fibrillation, multifocal atrial tachycardia, frequent ectopy
Key question: “Is the rhythm completely irregular, like a bag of worms?”
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Sudden onset and offset | Palpitations begin and end abruptly, like a switch | Paroxysmal supraventricular tachycardia, re-entrant arrhythmias |
| Gradual onset and offset | Heart rate accelerates and decelerates gradually | Sinus tachycardia, anxiety, exercise-related |
| Positional | Occurs when lying on left side or bending forward | Increased awareness due to cardiac-chest wall proximity, mitral valve prolapse |
| Exertional | Occurs during or after physical activity | Exercise-induced arrhythmias, catecholaminergic polymorphic ventricular tachycardia, coronary artery disease |
| Post-prandial | Occurs after eating, especially large meals | Vagal stimulation, gastrocardiac reflex, hiatal hernia |
| Nocturnal | Awakens patient from sleep | Obstructive sleep apnea, nocturnal atrial fibrillation, anxiety/panic disorder |
| Associated with syncope or near-syncope | Palpitations accompanied by lightheadedness or loss of consciousness | Ventricular tachycardia, rapid supraventricular tachycardia, bradyarrhythmias |
Key Concept: The Etiological Triad of Palpitations
When evaluating palpitations, systematically consider three major categories:
- Cardiac causes (approximately 43%): Arrhythmias (atrial fibrillation, supraventricular tachycardia, ventricular ectopy), structural heart disease, valvular disorders
- Psychiatric causes (approximately 31%): Anxiety disorders, panic attacks, depression, somatization
- Other/Miscellaneous causes (approximately 10%): Thyroid disorders, anemia, medications, caffeine, alcohol, electrolyte disturbances
- Unknown etiology (approximately 16%): No identifiable cause despite thorough workup
Impact on Quality of Life
Palpitations can significantly affect patients’ quality of life regardless of their underlying cause. Studies show that patients with palpitations report higher levels of anxiety, reduced functional capacity, and impaired work productivity. Even when arrhythmias are not detected, the symptom burden can be substantial. The psychological impact is particularly pronounced when episodes are unpredictable, occur in public settings, or are associated with fear of serious cardiac events. This underscores the importance of thorough evaluation and clear communication about prognosis, even when the underlying cause is benign.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of palpitations
Palpitations arise from the conscious perception of cardiac activity, which normally occurs without awareness. Understanding the pathophysiology requires knowledge of normal cardiac electrophysiology, the autonomic nervous system’s role in heart rate regulation, and the sensory pathways that transmit cardiac sensation to the brain. Palpitations can result from actual rhythm disturbances, changes in cardiac contractility, or heightened perception of normal cardiac activity.
Normal Cardiac Conduction System
| Component | Structure | Function |
|---|---|---|
| Sinoatrial Node | Located at junction of superior vena cava and right atrium | Primary pacemaker; generates impulses at 60-100 beats per minute; rate modulated by autonomic input |
| Atrioventricular Node | Located in the interatrial septum near the coronary sinus | Delays conduction to allow atrial contraction before ventricular activation; intrinsic rate 40-60 beats per minute |
| Bundle of His | Penetrates fibrous skeleton to enter interventricular septum | Transmits impulse from atrioventricular node to bundle branches |
| Bundle Branches and Purkinje Fibers | Right and left bundle branches divide into Purkinje network | Rapid distribution of impulse throughout ventricular myocardium for coordinated contraction |
Autonomic Regulation of Heart Rate
Sympathetic Nervous System
Neurotransmitter: Norepinephrine (and circulating epinephrine)
Receptors: Beta-1 adrenergic receptors on cardiac tissue
Effects:
- Increases heart rate (positive chronotropy)
- Increases contractility (positive inotropy)
- Increases conduction velocity through atrioventricular node
- Shortens refractory periods
Clinical relevance: Anxiety, exercise, hyperthyroidism, and stimulant use activate sympathetic tone, causing sinus tachycardia and heightened cardiac awareness
Parasympathetic Nervous System
Neurotransmitter: Acetylcholine
Receptors: Muscarinic M2 receptors on sinoatrial and atrioventricular nodes
Effects:
- Decreases heart rate (negative chronotropy)
- Slows atrioventricular nodal conduction
- Minimal effect on ventricular contractility
- Shortens atrial refractory period (may facilitate atrial fibrillation)
Clinical relevance: Vagal maneuvers can terminate supraventricular tachycardia; high vagal tone may predispose to “vagally-mediated” atrial fibrillation
Mechanisms of Cardiac Arrhythmias
Abnormal Automaticity
Mechanism: Cardiac cells outside the sinoatrial node develop spontaneous depolarization and act as ectopic pacemakers
Causes: Ischemia, electrolyte disturbances, catecholamine excess, digoxin toxicity
Examples: Atrial and ventricular ectopic beats, accelerated idioventricular rhythm
Re-entry
Mechanism: Impulse travels in a circuit due to unidirectional block and slow conduction in one pathway, allowing recovery of excitability in the blocked pathway
Requirements: Two pathways with different conduction velocities and refractory periods
Examples: Atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia (Wolff-Parkinson-White), atrial flutter, ventricular tachycardia
Triggered Activity
Mechanism: Afterdepolarizations (oscillations in membrane potential following an action potential) reach threshold and trigger additional impulses
Types: Early afterdepolarizations (occur during repolarization) and delayed afterdepolarizations (occur after repolarization)
Examples: Torsades de pointes (early afterdepolarizations), digoxin-induced arrhythmias (delayed afterdepolarizations)
How Conditions Cause Palpitations
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Premature Atrial Contractions | Ectopic atrial focus fires before the next expected sinus beat; the pause before the next normal beat creates a sensation of “skipping” | Usually benign; reduce triggers (caffeine, stress); beta-blockers if symptomatic |
| Premature Ventricular Contractions | Ventricular ectopic focus causes early, ineffective contraction followed by a compensatory pause; the subsequent beat is stronger than usual | Often benign; evaluate for structural heart disease if frequent (greater than 10% burden); consider ablation if cardiomyopathy develops |
| Atrioventricular Nodal Re-entrant Tachycardia | Dual atrioventricular nodal pathways create re-entry circuit; sudden onset and termination at rates of 150-250 beats per minute | Vagal maneuvers, adenosine for acute termination; catheter ablation is curative in over 95% of cases |
| Atrial Fibrillation | Multiple wavelets of electrical activity in the atria cause chaotic atrial activation and irregular ventricular response; loss of atrial contraction reduces cardiac output | Rate control, rhythm control, and anticoagulation for stroke prevention based on risk stratification |
| Ventricular Tachycardia | Re-entry or abnormal automaticity in ventricular tissue; often associated with structural heart disease or scar from prior infarction | Urgent evaluation; antiarrhythmic drugs, implantable cardioverter-defibrillator, or ablation depending on substrate |
| Anxiety and Panic Disorder | Catecholamine surge increases heart rate and contractility; heightened interoceptive awareness amplifies perception of normal cardiac activity | Cognitive behavioral therapy, selective serotonin reuptake inhibitors; beta-blockers for symptomatic relief; reassurance after cardiac workup |
| Hyperthyroidism | Thyroid hormone increases beta-adrenergic receptor sensitivity and has direct effects on cardiac myocytes, increasing heart rate and contractility | Treat underlying thyroid disorder; beta-blockers for symptomatic control until euthyroid |
| Anemia | Reduced oxygen-carrying capacity triggers compensatory increase in cardiac output through increased heart rate and stroke volume | Correct underlying anemia; palpitations resolve as hemoglobin normalizes |
| Mitral Valve Prolapse | Abnormal leaflet motion may trigger premature beats; associated dysautonomia causes heightened catecholamine sensitivity | Reassurance; beta-blockers if symptomatic; address associated anxiety |
Sensory Pathways and Perception
The perception of palpitations involves cardiac sensory afferents that travel via the vagus nerve and sympathetic fibers to the brainstem and ultimately to the somatosensory cortex. Several factors influence whether cardiac activity reaches conscious awareness:
Factors Increasing Palpitation Perception
- Quiet environment (nocturnal palpitations)
- Left lateral decubitus position (heart closer to chest wall)
- Thin body habitus
- Anxiety and heightened interoceptive awareness
- Prior cardiac events causing hypervigilance
- Forceful contractions (post-ectopic potentiation)
Factors Decreasing Palpitation Perception
- Physical activity and distraction
- Noisy environments
- Obesity (increased distance from heart to chest wall)
- Chronic arrhythmias (sensory adaptation)
- Neuropathy (reduced afferent signaling)
Often Overlooked Mechanism: The Post-Ectopic Potentiation
Patients often describe premature beats as a “skipped beat” followed by a “strong thump.” This is due to post-ectopic potentiation: the compensatory pause after a premature beat allows increased ventricular filling, and the subsequent sinus beat produces a more forceful contraction. Understanding this mechanism helps explain why patients often perceive the normal beat after the ectopic (not the ectopic itself) as the abnormal sensation.
Hemodynamic Consequences of Arrhythmias
| Arrhythmia Feature | Hemodynamic Effect | Clinical Manifestation |
|---|---|---|
| Rapid ventricular rate | Shortened diastolic filling time reduces stroke volume and coronary perfusion | Dyspnea, chest pain, hypotension, syncope |
| Loss of atrial contraction | Reduces ventricular filling by 15-25% (atrial kick); more significant in diastolic dysfunction | Fatigue, reduced exercise tolerance, heart failure exacerbation |
| Atrioventricular dyssynchrony | Atrial contraction against closed atrioventricular valves causes “cannon A waves” and reduced output | Neck pounding, presyncope, hypotension |
| Irregular rhythm | Variable stroke volume with short-long cycle sequences | Sensation of irregular heartbeat, pulse deficit |
| Tachycardia-induced cardiomyopathy | Chronic rapid rates cause ventricular remodeling and systolic dysfunction | Progressive heart failure; potentially reversible with rate or rhythm control |
3. History Taking
A comprehensive approach to eliciting the palpitation history
Red Flags — Require Urgent Evaluation
- Syncope or near-syncope — Suggests hemodynamically significant arrhythmia (ventricular tachycardia, rapid supraventricular tachycardia)
- Chest pain with palpitations — May indicate ischemia, especially if exertional
- Severe dyspnea — Suggests hemodynamic compromise or heart failure
- Known structural heart disease — Higher risk of ventricular arrhythmias
- Family history of sudden cardiac death — Consider inherited arrhythmia syndromes or cardiomyopathy
- Palpitations during exertion — May indicate catecholaminergic polymorphic ventricular tachycardia or ischemia
- Very rapid heart rate (greater than 150 beats per minute) — Suggests significant tachyarrhythmia
- Prolonged episodes (greater than 30 minutes) — Higher likelihood of sustained arrhythmia requiring intervention
Systematic History: The “HEARTS” Approach
Use the mnemonic “HEARTS” to ensure comprehensive history taking for palpitations:
- H — How does it feel?: Character of palpitations (racing, skipping, pounding, fluttering, irregular)
- E — Episode details: Onset (sudden vs gradual), duration, frequency, termination (spontaneous vs requires intervention)
- A — Associated symptoms: Syncope, presyncope, chest pain, dyspnea, diaphoresis, polyuria (suggests supraventricular tachycardia)
- R — Rate and rhythm: Ask patient to tap out the rhythm; estimate rate (count pulse during episode if possible)
- T — Triggers and timing: Exercise, stress, caffeine, alcohol, position, sleep, meals, menstrual cycle
- S — Stopping maneuvers: Do vagal maneuvers (breath-holding, cold water, bearing down) terminate the episode? Suggests supraventricular tachycardia
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Premature beats (atrial or ventricular) | Skipped beats, pause followed by thump, irregular but not sustained | “Do you feel like your heart skips a beat and then gives a strong thump? How often does this happen?” |
| Supraventricular tachycardia | Sudden onset and offset, regular rapid rate, may terminate with vagal maneuvers | “Does your heart suddenly start racing and then suddenly stop, like flipping a switch? Can you stop it by holding your breath or bearing down?” |
| Atrial fibrillation | Irregular rhythm, may have gradual or sudden onset, variable rate | “Is the rhythm completely irregular, or is it fast but regular? Do you notice any pattern to the irregularity?” |
| Ventricular tachycardia | Rapid regular rhythm, often associated with syncope or presyncope, history of heart disease | “Do you feel faint or actually lose consciousness during episodes? Have you ever had a heart attack or been told you have heart muscle problems?” |
| Anxiety or panic disorder | Palpitations with fear, tremor, sweating, paresthesias; may occur at rest | “Do you feel anxious or afraid during episodes? Do you experience numbness, tingling, or a sense of doom?” |
| Hyperthyroidism | Palpitations with heat intolerance, weight loss, tremor, irritability | “Have you noticed weight loss despite a good appetite? Do you feel hot when others are comfortable? Any tremor or anxiety?” |
| Anemia | Palpitations with fatigue, dyspnea on exertion, pallor | “Do you feel tired or short of breath with activity? Have you noticed any blood loss or changes in your stools?” |
| Stimulant or substance use | Temporal relationship to caffeine, alcohol, cocaine, amphetamines, energy drinks | “How much coffee, tea, or energy drinks do you consume daily? Do you use any recreational drugs? Do episodes occur after drinking alcohol?” |
| Medication-induced | Temporal relationship to starting or adjusting medications | “Have you started any new medications recently? Are you using any inhalers, decongestants, or over-the-counter supplements?” |
| Wolff-Parkinson-White syndrome | Young patient, very rapid rates, may have pre-excitation on baseline electrocardiogram | “Have you had palpitations since you were young? During episodes, is your heart rate extremely fast—like 200 or more beats per minute?” |
Essential Additional History Elements
Cardiac History
- Prior cardiac diagnoses: Coronary artery disease, heart failure, cardiomyopathy, valvular disease, congenital heart disease
- Prior arrhythmias: Previous episodes, electrocardiogram findings, prior ablation or cardioversion
- Cardiac procedures: Prior cardiac surgery, catheterization, device implantation
- Cardiovascular risk factors: Hypertension, diabetes, hyperlipidemia, smoking, obesity
Family History
Critical Family History Questions
Always ask about family history of:
- Sudden cardiac death — especially in relatives under age 50
- Unexplained syncope or drowning — may indicate channelopathy
- Cardiomyopathy — hypertrophic, dilated, or arrhythmogenic right ventricular
- Pacemaker or defibrillator implantation — suggests inherited arrhythmia syndrome
- Known inherited conditions: Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia
Medication and Substance History
Medications That Cause Palpitations
- Beta-agonists (salbutamol, formoterol) — Direct beta-adrenergic stimulation
- Theophylline — Phosphodiesterase inhibition, adenosine antagonism
- Decongestants (pseudoephedrine, phenylephrine) — Sympathomimetic effects
- Thyroid hormone — Excess causes hyperdynamic state
- Digoxin — Toxicity causes various arrhythmias
- Antiarrhythmics — Proarrhythmic effects paradoxically cause arrhythmias
- Stimulant medications (methylphenidate, amphetamines) — Direct sympathetic activation
- Antidepressants (tricyclics, some selective serotonin reuptake inhibitors) — QT prolongation, anticholinergic effects
- Antipsychotics — QT prolongation
- Fluoroquinolones — QT prolongation
- Macrolides (erythromycin, clarithromycin) — QT prolongation
Substances and Lifestyle Factors
- Caffeine: Quantify daily intake (coffee, tea, energy drinks, cola, chocolate); threshold varies by individual
- Alcohol: Acute intoxication and withdrawal both cause arrhythmias; “holiday heart” syndrome
- Tobacco: Nicotine causes sympathetic activation
- Cocaine: Potent sympathomimetic; causes coronary vasospasm and arrhythmias
- Amphetamines and methamphetamine: Direct sympathetic activation
- Cannabis: May cause tachycardia and atrial fibrillation
- Energy drinks: High caffeine plus other stimulants (taurine, guarana)
- Supplements: Ephedra, bitter orange, weight loss supplements
Social and Occupational Considerations
| Factor | Relevance | Key Questions |
|---|---|---|
| Occupation | Safety-sensitive occupations (pilots, drivers, heavy machinery operators) have implications for arrhythmia management | “What is your occupation? Would losing consciousness at work pose a danger to you or others?” |
| Exercise and athletics | Endurance athletes have higher rates of atrial fibrillation; exercise-induced arrhythmias are important | “How often and how intensely do you exercise? Do palpitations occur during or after exercise?” |
| Sleep patterns | Sleep apnea is a major risk factor for atrial fibrillation; nocturnal symptoms may indicate apnea | “Do you snore? Has anyone witnessed you stop breathing during sleep? Do you wake up with palpitations?” |
| Stress and mental health | Anxiety, depression, and chronic stress contribute to palpitation perception and arrhythmia triggers | “How would you rate your stress level? Do you experience anxiety or panic attacks?” |
| Driving | Syncope with palpitations may have driving restrictions depending on diagnosis | “Have you ever felt faint or lost consciousness while driving? Do palpitations affect your ability to concentrate?” |
Clinical Pearl: The Palpitation Diary
Encourage patients to keep a symptom diary recording:
- Date and time of each episode
- Duration of episode
- Estimated heart rate (teach patient to count pulse)
- Associated symptoms
- Preceding activities (exercise, caffeine, stress, meals)
- What terminated the episode
This information is invaluable for correlating symptoms with ambulatory monitoring findings and identifying triggers.
4. Physical Examination
A systematic approach for patients presenting with palpitations
Systematic Framework: The physical examination in patients with palpitations aims to: (1) identify signs of hemodynamic compromise, (2) detect underlying structural heart disease, (3) identify systemic conditions causing palpitations, and (4) assess cardiovascular risk factors. Use a “Head to Extremities” approach with focused cardiovascular examination.
General Inspection
- Appearance: Anxiety, distress, diaphoresis; body habitus (Marfan syndrome features suggest mitral valve prolapse or aortic disease)
- Respiratory effort: Tachypnea, use of accessory muscles (suggests heart failure or pulmonary disease)
- Color: Pallor (anemia), plethora (polycythemia), jaundice (liver disease with alcohol-related cardiomyopathy)
- Nutritional status: Cachexia (malignancy, chronic heart failure), obesity (sleep apnea, metabolic syndrome)
- Tremor: Fine tremor suggests hyperthyroidism or anxiety
- Diaphoresis: May indicate hyperthyroidism, hypoglycemia, or acute distress
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Rate, rhythm (regular vs irregular), pulse deficit | Tachycardia at rest may indicate ongoing arrhythmia, hyperthyroidism, anemia, anxiety; bradycardia may indicate sick sinus syndrome; irregular rhythm suggests atrial fibrillation or frequent ectopy |
| Blood Pressure | Hypertension, hypotension, wide pulse pressure, pulsus alternans | Hypertension is risk factor for atrial fibrillation and left ventricular hypertrophy; hypotension with palpitations suggests hemodynamic compromise; wide pulse pressure in aortic regurgitation or hyperthyroidism |
| Respiratory Rate | Tachypnea at rest | May indicate heart failure, pulmonary embolism, or anxiety; hyperventilation during panic attack |
| Oxygen Saturation | Hypoxemia (less than 94%) | Hypoxia can trigger arrhythmias; may indicate underlying cardiopulmonary disease |
| Temperature | Fever | Fever causes sinus tachycardia; may indicate endocarditis, thyroid storm, or infection triggering atrial fibrillation |
| Orthostatic Vital Signs | Heart rate increase greater than 30 beats per minute or blood pressure drop greater than 20/10 mmHg on standing | Postural orthostatic tachycardia syndrome presents with palpitations and presyncope; dehydration and autonomic dysfunction |
Head and Neck Examination
Eyes
- Exophthalmos: Graves disease and hyperthyroidism
- Lid lag and lid retraction: Thyroid eye disease
- Pallor of conjunctivae: Anemia
- Xanthelasma: Hyperlipidemia and coronary artery disease risk
Thyroid
- Goiter: Suggests thyroid pathology
- Thyroid nodules: May be associated with thyroid dysfunction
- Thyroid bruit: Increased vascularity in Graves disease
- Tenderness: Thyroiditis
Jugular Venous Pressure
- Elevated jugular venous pressure: Right heart failure, tricuspid regurgitation, pericardial disease
- Cannon A waves: Atrial contraction against closed tricuspid valve (atrioventricular dissociation, complete heart block, ventricular tachycardia)
- Irregular jugular venous pulsations: Atrial fibrillation (absent A waves)
- Giant V waves: Tricuspid regurgitation
Carotid Arteries
- Carotid bruits: Atherosclerotic disease
- Corrigan pulse (water-hammer): Aortic regurgitation
- Pulsus parvus et tardus: Aortic stenosis
Cardiovascular Examination
Inspection
- Visible apex beat: May indicate left ventricular hypertrophy or dilation
- Chest wall deformities: Pectus excavatum (associated with mitral valve prolapse), scoliosis
- Surgical scars: Sternotomy, thoracotomy, pacemaker/defibrillator pocket
- Visible pulsations: Abnormal pulsations may indicate aneurysm or hyperdynamic circulation
Palpation
- Apex beat location: Lateral displacement suggests left ventricular dilation; sustained and forceful suggests left ventricular hypertrophy
- Right ventricular heave: Left parasternal lift indicates right ventricular hypertrophy or dilation
- Thrills: Palpable murmurs indicating significant valvular disease
- Pacemaker or defibrillator pocket: Check for signs of infection, erosion, or appropriate placement
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Irregularly irregular rhythm | Completely unpredictable timing between beats | Atrial fibrillation, multifocal atrial tachycardia, frequent ectopy |
| Regularly irregular rhythm | Predictable pattern of irregularity (e.g., every third beat) | Bigeminy, trigeminy, second-degree atrioventricular block |
| Third heart sound (S3) | Low-pitched early diastolic sound; “ventricular gallop” | Heart failure with reduced ejection fraction, volume overload |
| Fourth heart sound (S4) | Late diastolic sound before S1; “atrial gallop” | Left ventricular hypertrophy, diastolic dysfunction, acute ischemia |
| Mid-systolic click with late systolic murmur | Click occurs in mid-systole; murmur crescendos to S2 | Mitral valve prolapse |
| Harsh crescendo-decrescendo systolic murmur | Best heard at right upper sternal border; radiates to carotids | Aortic stenosis |
| Blowing early diastolic murmur | Decrescendo murmur at left sternal border; best heard sitting forward | Aortic regurgitation |
| Holosystolic murmur at apex | Blowing murmur radiating to axilla | Mitral regurgitation |
| Pericardial friction rub | Scratchy, high-pitched sound; may have 1-3 components | Pericarditis (may cause palpitations from inflammation or associated arrhythmias) |
| Variable intensity of S1 | S1 varies in loudness from beat to beat | Atrial fibrillation, complete heart block with atrioventricular dissociation |
Respiratory Examination
- Crackles (rales): Pulmonary edema from heart failure or tachycardia-induced cardiomyopathy
- Wheezing: May be “cardiac asthma” from left heart failure; also consider bronchospasm from beta-agonist use
- Pleural effusion: Dullness to percussion with reduced breath sounds; seen in heart failure
- Respiratory pattern: Cheyne-Stokes respiration in advanced heart failure
Abdominal Examination
- Hepatomegaly: Right heart failure, hepatic congestion
- Pulsatile liver: Tricuspid regurgitation
- Hepatojugular reflux: Right heart failure
- Ascites: Advanced right heart failure, constrictive pericarditis
- Abdominal obesity: Metabolic syndrome, obstructive sleep apnea risk
Extremities
Upper Extremities
- Tremor: Fine tremor of hyperthyroidism or anxiety
- Warm, moist palms: Hyperthyroidism, anxiety
- Splinter hemorrhages: Infective endocarditis
- Janeway lesions and Osler nodes: Infective endocarditis
- Radial pulse assessment: Rate, rhythm, character; radiofemoral delay (coarctation)
Lower Extremities
- Peripheral edema: Right heart failure, venous insufficiency
- Calf swelling and tenderness: Deep vein thrombosis (consider pulmonary embolism if palpitations)
- Peripheral pulses: Diminished in peripheral vascular disease
- Cyanosis: Peripheral or central; suggests hypoxemia or poor perfusion
- Clubbing: Congenital heart disease, chronic hypoxemia
Special Maneuvers
| Maneuver | Technique | Purpose and Findings |
|---|---|---|
| Valsalva maneuver | Patient bears down against closed glottis for 10-15 seconds | May terminate supraventricular tachycardia; increases murmur of hypertrophic cardiomyopathy; click of mitral valve prolapse moves earlier |
| Squatting to standing | Patient squats then rapidly stands | Decreases preload; click of mitral valve prolapse moves earlier; murmur of hypertrophic cardiomyopathy increases |
| Handgrip | Patient squeezes examiner’s hands tightly | Increases afterload; mitral regurgitation and aortic regurgitation murmurs increase; hypertrophic cardiomyopathy murmur decreases |
| Carotid sinus massage | Gentle massage of carotid sinus (after ensuring no bruits) | May terminate supraventricular tachycardia; slows ventricular rate in atrial fibrillation/flutter; use with caution in elderly |
Expected Findings by Etiology
| Condition | General | Cardiovascular | Other Findings |
|---|---|---|---|
| Benign ectopy | Normal appearance | Occasional irregular beat; otherwise normal | None |
| Supraventricular tachycardia | May appear anxious during episode | Regular tachycardia 150-250 bpm during episode; often normal between episodes | Polyuria may occur after episode terminates |
| Atrial fibrillation | Variable; may be asymptomatic | Irregularly irregular rhythm, variable S1, pulse deficit | Signs of underlying cause (heart failure, hyperthyroidism, alcohol) |
| Ventricular tachycardia | May be hemodynamically unstable | Rapid regular rhythm; cannon A waves in jugular venous pressure; variable S1 | Signs of structural heart disease; previous myocardial infarction scars |
| Anxiety/panic disorder | Anxious appearance, hyperventilation, diaphoresis | Sinus tachycardia; otherwise normal | Tremor, cold and clammy extremities, sighing respirations |
| Hyperthyroidism | Agitated, warm, weight loss | Resting tachycardia, wide pulse pressure, flow murmur | Exophthalmos, lid lag, goiter, thyroid bruit, fine tremor, warm moist skin |
| Anemia | Pallor, fatigue | Tachycardia, flow murmur, hyperdynamic precordium | Conjunctival pallor, koilonychia, glossitis (depending on cause) |
| Mitral valve prolapse | Often young, slender female; may have Marfanoid features | Mid-systolic click with or without late systolic murmur | Pectus excavatum, scoliosis, joint hypermobility |
| Hypertrophic cardiomyopathy | May appear normal; athlete habitus | Harsh systolic murmur increasing with Valsalva; bisferiens pulse; S4 | May have normal examination; family history of sudden death |
Important Teaching Point
Normal examination is common! Many causes of palpitations present with entirely normal physical examination findings, particularly when the patient is examined between episodes. Benign premature beats, paroxysmal supraventricular tachycardia, anxiety-related palpitations, and even paroxysmal atrial fibrillation often have completely normal examinations at rest. A normal physical examination does not exclude significant arrhythmia, and ambulatory monitoring is often necessary to capture the rhythm during symptoms.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of palpitations is broad, encompassing cardiac arrhythmias, structural heart disease, systemic conditions, psychiatric disorders, and substance-related causes. A systematic approach based on probability helps prioritize the workup and avoid missing serious diagnoses while not over-investigating benign conditions.
Etiological Breakdown of Palpitations:
- Cardiac causes (approximately 43%): Arrhythmias account for the majority; structural heart disease is an important substrate
- Psychiatric causes (approximately 31%): Anxiety and panic disorder are extremely common, often coexisting with cardiac causes
- Miscellaneous causes (approximately 10%): Thyroid disorders, anemia, medications, stimulants
- Unknown etiology (approximately 16%): No cause identified despite comprehensive workup
Cardiac Arrhythmias Causing Palpitations
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 40-50%) | Premature atrial contractions | Skipped beats, pause then thump; often precipitated by caffeine, stress, fatigue | Usually benign; concern if very frequent or in structural heart disease |
| COMMON | Premature ventricular contractions | Skipped beats with stronger subsequent beat; may feel like “flopping” in chest | Evaluate if greater than 10% burden, symptoms of heart failure, or structural heart disease |
| COMMON | Sinus tachycardia | Gradual onset and offset; rate typically 100-150 beats per minute; appropriate response to stimulus | Search for underlying cause (fever, anemia, hyperthyroidism, anxiety, hypovolemia) |
| LESS COMMON (approximately 10-15%) | Atrial fibrillation | Irregularly irregular rhythm; may be paroxysmal or persistent; risk increases with age | Stroke risk assessment required; rapid ventricular response may cause hemodynamic compromise |
| LESS COMMON | Atrioventricular nodal re-entrant tachycardia | Sudden onset and offset; regular rapid rate 150-250 beats per minute; common in young women; may terminate with vagal maneuvers | Usually well-tolerated; rarely causes syncope |
| LESS COMMON | Atrial flutter | Regular or regularly irregular rhythm; classic “sawtooth” pattern on electrocardiogram; often 150 beats per minute (2:1 block) | Similar stroke risk to atrial fibrillation; may degenerate to atrial fibrillation |
| LESS COMMON | Atrioventricular re-entrant tachycardia (including Wolff-Parkinson-White syndrome) | Sudden onset; very rapid rates possible; may have pre-excitation on baseline electrocardiogram | Risk of rapid conduction during atrial fibrillation leading to ventricular fibrillation |
| UNCOMMON BUT SERIOUS (approximately 5%) | Ventricular tachycardia | Rapid regular wide-complex tachycardia; often associated with structural heart disease or prior myocardial infarction | Syncope, presyncope, or cardiac arrest; requires urgent evaluation and treatment |
| UNCOMMON BUT SERIOUS | Sick sinus syndrome (tachy-brady syndrome) | Alternating bradycardia and tachycardia; often elderly patients | May cause syncope; often requires pacemaker |
| UNCOMMON BUT SERIOUS | Long QT syndrome | Palpitations, syncope, or cardiac arrest; may be congenital or acquired (drugs) | Torsades de pointes; sudden cardiac death; family history of sudden death |
| UNCOMMON BUT SERIOUS | Catecholaminergic polymorphic ventricular tachycardia | Exercise or emotional stress-induced ventricular arrhythmias; usually in young patients | Syncope during exercise; family history of sudden death or drowning |
Non-Arrhythmic Cardiac Causes
| Probability | Condition | Mechanism | Key Features |
|---|---|---|---|
| COMMON | Mitral valve prolapse | Abnormal valve motion triggers ectopy; associated dysautonomia | Mid-systolic click; often young women; benign in most cases |
| LESS COMMON | Aortic regurgitation | Hyperdynamic circulation with large stroke volume | Bounding pulses, wide pulse pressure, diastolic murmur |
| LESS COMMON | Hypertrophic cardiomyopathy | Substrate for ventricular arrhythmias; outflow obstruction | Systolic murmur increasing with Valsalva; family history of sudden death |
| UNCOMMON | Dilated cardiomyopathy | Substrate for atrial and ventricular arrhythmias | Heart failure symptoms; S3 gallop; cardiomegaly |
| UNCOMMON | Arrhythmogenic right ventricular cardiomyopathy | Fibrofatty replacement of right ventricle creates arrhythmia substrate | Exercise-induced ventricular arrhythmias; family history; epsilon wave on electrocardiogram |
| UNCOMMON | Atrial myxoma | Tumor causes intermittent valve obstruction and arrhythmias | Positional symptoms; systemic embolization; constitutional symptoms |
Non-Cardiac Causes of Palpitations
Step-by-Step Approach to Non-Cardiac Causes:
- Step 1: Exclude psychiatric causes — Anxiety, panic disorder, depression, somatization (approximately 30% of cases)
- Step 2: Check for metabolic and endocrine causes — Thyroid function, electrolytes, glucose, hemoglobin
- Step 3: Review medications and substances — Stimulants, caffeine, alcohol, recreational drugs
- Step 4: Consider autonomic disorders — Postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia
| Category | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| PSYCHIATRIC | Anxiety disorder | 20-30% of palpitation presentations | Palpitations associated with worry, tension; chronic symptoms; may occur at rest |
| PSYCHIATRIC | Panic disorder | 15-20% of palpitation presentations | Discrete episodes with intense fear, dyspnea, diaphoresis, paresthesias, sense of doom |
| PSYCHIATRIC | Depression | 5-10% | Palpitations with low mood, anhedonia, sleep disturbance, appetite changes |
| ENDOCRINE | Hyperthyroidism | 5-10% | Weight loss, heat intolerance, tremor, anxiety, goiter, exophthalmos |
| ENDOCRINE | Pheochromocytoma | Less than 1% | Episodic hypertension, headache, diaphoresis; “spells” lasting minutes to hours |
| ENDOCRINE | Hypoglycemia | Variable | Palpitations with tremor, sweating, confusion; temporal relationship to meals or insulin |
| HEMATOLOGIC | Anemia | 5% | Fatigue, dyspnea on exertion, pallor; palpitations worse with activity |
| AUTONOMIC | Postural orthostatic tachycardia syndrome | Variable | Tachycardia (greater than 30 beats per minute increase) on standing; young women; fatigue, lightheadedness |
| AUTONOMIC | Inappropriate sinus tachycardia | Rare | Elevated resting heart rate (greater than 100 beats per minute) without identifiable cause; exclusion diagnosis |
Mechanistic Approach to Palpitations
Tachyarrhythmias
Sinus tachycardia
Atrial fibrillation/flutter
Supraventricular tachycardia
Ventricular tachycardia
Wolff-Parkinson-White syndrome
Ectopic Beats
Premature atrial contractions
Premature ventricular contractions
Atrial and ventricular couplets
Non-sustained ventricular tachycardia
Hyperdynamic States
Anxiety and stress
Hyperthyroidism
Anemia
Fever and sepsis
Pregnancy
Aortic regurgitation
Bradyarrhythmias
Sick sinus syndrome
Heart block with escape beats
Pacemaker-mediated tachycardia
Post-pause potentiation
Drug-Induced Palpitations
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Beta-agonists (salbutamol, formoterol, salmeterol) | Beta-adrenergic stimulation causing tachycardia and ectopy | Dose-related; sinus tachycardia, tremor, hypokalemia | Minimize dose; consider alternative bronchodilators if severe |
| Theophylline | Phosphodiesterase inhibition; adenosine antagonism | Narrow therapeutic window; tachycardia, atrial and ventricular arrhythmias | Monitor drug levels; dose reduction |
| Sympathomimetic decongestants (pseudoephedrine, phenylephrine) | Alpha and beta-adrenergic stimulation | Tachycardia, hypertension, ectopy; over-the-counter availability | Avoid in patients with cardiac disease; consider alternatives |
| Stimulant medications (methylphenidate, amphetamines) | Catecholamine release and reuptake inhibition | Dose-related tachycardia; may exacerbate underlying arrhythmias | Cardiovascular screening before initiation; dose adjustment |
| Thyroid hormone (levothyroxine) — excess | Hyperthyroid state from over-replacement | Sinus tachycardia, atrial fibrillation; symptoms of thyrotoxicosis | Check thyroid-stimulating hormone; dose reduction |
| Digoxin — toxicity | Multiple mechanisms including enhanced automaticity and triggered activity | Any arrhythmia possible; classically atrial tachycardia with block, bidirectional ventricular tachycardia | Check digoxin level, potassium; withhold drug; digoxin-specific antibody if severe |
| QT-prolonging drugs (antiarrhythmics, antipsychotics, antibiotics) | Delayed repolarization leading to early afterdepolarizations | Torsades de pointes; syncope; risk increases with hypokalemia, hypomagnesemia | Baseline and serial electrocardiograms; avoid drug combinations; correct electrolytes |
| Tricyclic antidepressants | Anticholinergic effects; sodium channel blockade; QT prolongation | Sinus tachycardia; widened QRS in overdose; ventricular arrhythmias | Electrocardiogram monitoring; avoid in cardiac disease |
| Caffeine | Adenosine antagonism; catecholamine release | Sinus tachycardia; increased ectopy; dose-response relationship | Quantify intake; gradual reduction to avoid withdrawal |
| Alcohol | Direct toxicity; autonomic effects; electrolyte disturbances | “Holiday heart” — atrial fibrillation after binge drinking; chronic use causes cardiomyopathy | Abstinence; electrolyte replacement; address alcohol use disorder |
| Cocaine | Sympathomimetic effects; coronary vasospasm; sodium channel blockade | Severe tachycardia, hypertension; ventricular arrhythmias; myocardial ischemia | Benzodiazepines for acute toxicity; avoid beta-blockers (unopposed alpha) |
| Cannabis | Sympathetic activation; direct effects on cardiac ion channels | Sinus tachycardia; reports of atrial fibrillation, especially with synthetic cannabinoids | Counseling regarding cardiac effects; cessation |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Sudden onset and offset, regular rapid rate, terminates with vagal maneuvers | Atrioventricular nodal re-entrant tachycardia or atrioventricular re-entrant tachycardia | Electrocardiogram during episode; consider electrophysiology study |
| Irregularly irregular pulse with variable pulse intensity | Atrial fibrillation | Electrocardiogram; assess stroke risk; echocardiogram |
| Skipped beat followed by strong thump | Premature ventricular or atrial contractions | Electrocardiogram; Holter if frequent or symptomatic |
| Palpitations with syncope or near-syncope | Ventricular tachycardia, rapid supraventricular tachycardia, or bradyarrhythmia | Urgent evaluation; prolonged monitoring; echocardiogram |
| Palpitations during exercise in young patient | Catecholaminergic polymorphic ventricular tachycardia, hypertrophic cardiomyopathy | Exercise stress testing with rhythm monitoring; echocardiogram; genetic testing |
| Palpitations with weight loss, heat intolerance, tremor | Hyperthyroidism | Thyroid-stimulating hormone, free T4; thyroid examination |
| Palpitations with anxiety, paresthesias, sense of doom | Panic disorder | Cardiac workup to exclude arrhythmia; psychiatric evaluation |
| Palpitations with fatigue, dyspnea, pallor | Anemia | Complete blood count; reticulocyte count; iron studies |
| Palpitations worse on standing, relieved by lying down | Postural orthostatic tachycardia syndrome | Orthostatic vital signs; tilt table testing |
| Family history of sudden cardiac death under age 50 | Inherited arrhythmia syndrome or cardiomyopathy | Electrocardiogram; echocardiogram; consider genetic testing and family screening |
| Palpitations after starting new medication | Drug-induced arrhythmia or sinus tachycardia | Review medication list; check electrocardiogram for QT prolongation |
| Polyuria after palpitation episode terminates | Supraventricular tachycardia (atrial natriuretic peptide release) | Characteristic of supraventricular tachycardia; arrange electrophysiology study if recurrent |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The investigation of palpitations should be guided by the clinical history, physical examination, and pre-test probability of significant arrhythmia. The primary goal is to capture a rhythm strip during symptoms (symptom-rhythm correlation). A stepwise approach prevents unnecessary testing while ensuring serious conditions are not missed.
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| 12-Lead Electrocardiogram | Identify arrhythmia, conduction abnormalities, pre-excitation, structural heart disease clues | Rate and rhythm; PR, QRS, QT intervals; pre-excitation (delta wave); Q waves; ST-T changes; left ventricular hypertrophy; epsilon wave | Obtain during symptoms if possible; compare to prior electrocardiograms; normal electrocardiogram does not exclude arrhythmia |
| Complete Blood Count | Exclude anemia as cause of hyperdynamic state | Hemoglobin less than 120 g/L (women) or less than 130 g/L (men); mean corpuscular volume for classification | Anemia causes compensatory tachycardia; correct anemia before extensive arrhythmia workup |
| Thyroid-Stimulating Hormone | Exclude hyperthyroidism or hypothyroidism | Low thyroid-stimulating hormone suggests hyperthyroidism; high thyroid-stimulating hormone suggests hypothyroidism | Hyperthyroidism causes sinus tachycardia and atrial fibrillation; even subclinical hyperthyroidism increases atrial fibrillation risk |
| Basic Metabolic Panel (Electrolytes, Creatinine, Glucose) | Identify electrolyte abnormalities that predispose to arrhythmias | Potassium less than 3.5 or greater than 5.0 mmol/L; magnesium less than 0.7 mmol/L; glucose abnormalities | Hypokalemia and hypomagnesemia lower threshold for arrhythmias; correct before antiarrhythmic therapy |
Key Electrocardiogram Findings in Palpitation Evaluation
| Finding | Description | Clinical Significance |
|---|---|---|
| Delta wave (pre-excitation) | Slurred upstroke of QRS complex; short PR interval (less than 120 ms) | Wolff-Parkinson-White syndrome; risk of rapid conduction during atrial fibrillation |
| Prolonged QT interval | QTc greater than 470 ms (men) or greater than 480 ms (women) | Long QT syndrome; risk of torsades de pointes; review medications |
| Short QT interval | QTc less than 340 ms | Short QT syndrome; risk of atrial fibrillation and sudden cardiac death |
| Epsilon wave | Small positive deflection at end of QRS in V1-V3 | Arrhythmogenic right ventricular cardiomyopathy |
| Brugada pattern | Coved ST elevation greater than 2 mm in V1-V2 with T-wave inversion | Brugada syndrome; risk of ventricular fibrillation |
| Left ventricular hypertrophy with strain | Voltage criteria plus ST depression and T-wave inversion in lateral leads | Hypertrophic cardiomyopathy or hypertensive heart disease; substrate for arrhythmias |
| Q waves | Pathological Q waves (greater than 40 ms wide, greater than 25% of R wave amplitude) | Prior myocardial infarction; substrate for ventricular arrhythmias |
| Frequent ectopy | Premature atrial or ventricular complexes on resting electrocardiogram | Suggests ectopy as cause of symptoms; quantify with Holter monitoring |
Ambulatory Rhythm Monitoring
Key Principle: The goal of ambulatory monitoring is to achieve symptom-rhythm correlation — documenting the heart rhythm at the exact time the patient experiences palpitations. The choice of monitor depends on symptom frequency.
| Monitor Type | Duration | Best For | Practical Considerations |
|---|---|---|---|
| 24-Hour Holter Monitor | 24-48 hours | Daily or near-daily symptoms; quantifying ectopy burden | Diagnostic yield only 15-30% for infrequent palpitations; good for frequent ectopy or assessing rate control |
| Extended Holter Monitor | 7-14 days | Symptoms occurring several times per week | Higher yield than 24-hour Holter; modern patches are waterproof and more comfortable |
| Event Monitor (Patient-Activated) | 2-4 weeks | Infrequent but memorable symptoms; patient activates when symptomatic | Requires patient to be conscious and able to activate; may miss brief episodes |
| Mobile Cardiac Telemetry | Up to 30 days | Infrequent symptoms; higher-risk patients needing real-time monitoring | Continuous monitoring with automatic arrhythmia detection; more expensive but higher yield |
| Implantable Loop Recorder | Up to 3 years | Very infrequent symptoms (monthly or less); syncope with suspected arrhythmia; cryptogenic stroke | Requires minor procedure for insertion; highest yield for rare events; automatic detection plus patient activation |
| Smartphone/Smartwatch Electrocardiogram | Indefinite (patient-owned device) | Paroxysmal symptoms in tech-savvy patients; screening for atrial fibrillation | Single-lead only; quality variable; useful adjunct but may miss some arrhythmias |
Targeted Investigations by Suspected Etiology
If Suspecting Structural Heart Disease
First-Line Tests
- Transthoracic Echocardiogram: Assess left ventricular function (ejection fraction), valvular disease, left atrial size, right ventricular function, cardiomyopathy features
- Chest X-Ray: Cardiomegaly, pulmonary congestion, pulmonary pathology
Second-Line Tests
- Cardiac MRI: Gold standard for cardiomyopathy characterization; identifies scar, fibrosis, arrhythmogenic right ventricular cardiomyopathy features
- Coronary Assessment: CT coronary angiography or invasive angiography if ischemia suspected
If Suspecting Supraventricular Tachycardia
First-Line Tests
- 12-Lead Electrocardiogram: Look for pre-excitation (delta wave), abnormal P-wave morphology
- Ambulatory Monitoring: Capture episode to characterize mechanism
Second-Line Tests
- Electrophysiology Study: Diagnostic and therapeutic; identifies mechanism (atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia, atrial tachycardia); ablation can be performed
- Adenosine Challenge: May unmask pre-excitation or atrial arrhythmias
If Suspecting Ventricular Arrhythmia
First-Line Tests
- Electrocardiogram: Q waves (prior infarction), QT prolongation, Brugada pattern, epsilon waves
- Echocardiogram: Ejection fraction, regional wall motion abnormalities, cardiomyopathy
- Ambulatory Monitoring: Characterize and quantify ventricular ectopy
Second-Line Tests
- Cardiac MRI: Scar characterization, arrhythmogenic right ventricular cardiomyopathy diagnosis
- Signal-Averaged Electrocardiogram: Detects late potentials suggesting substrate for re-entry
- Electrophysiology Study: Inducibility of ventricular tachycardia; may guide implantable cardioverter-defibrillator decision
- Genetic Testing: If inherited arrhythmia syndrome suspected
If Suspecting Atrial Fibrillation
First-Line Tests
- Electrocardiogram: Confirm diagnosis; assess ventricular rate
- Echocardiogram: Left atrial size, left ventricular function, valvular disease
- Thyroid-Stimulating Hormone: Exclude hyperthyroidism
Second-Line Tests
- Transesophageal Echocardiogram: Before cardioversion to exclude left atrial appendage thrombus (if anticoagulation duration uncertain)
- Sleep Study: If obstructive sleep apnea suspected (strong association with atrial fibrillation)
- Additional Metabolic Testing: Alcohol history, electrolytes
Exercise Stress Testing
When to Order Exercise Testing
- Exertional palpitations: To reproduce symptoms and capture rhythm during exercise
- Suspected catecholaminergic polymorphic ventricular tachycardia: Characteristic bidirectional or polymorphic ventricular tachycardia during exercise
- Suspected exercise-induced supraventricular tachycardia: May provoke and characterize arrhythmia
- Risk stratification: After myocardial infarction or in patients with coronary artery disease
- Evaluation of rate response: Chronotropic incompetence or excessive heart rate response
Caution: Ensure adequate supervision and resuscitation equipment available; contraindicated in patients with known unstable arrhythmias or severe structural heart disease without appropriate precautions.
Electrophysiology Study
| Indication | What It Reveals | Therapeutic Potential |
|---|---|---|
| Recurrent supraventricular tachycardia | Mechanism (atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia, atrial tachycardia); location of accessory pathway | Catheter ablation curative in greater than 95% of cases |
| Wolff-Parkinson-White syndrome | Accessory pathway location; risk stratification based on pathway properties | Ablation eliminates risk of sudden death from rapid atrial fibrillation |
| Atrial flutter | Flutter circuit characterization (typical versus atypical) | Cavotricuspid isthmus ablation highly effective for typical flutter |
| Ventricular tachycardia | Inducibility; mechanism; mapping for ablation | Ablation may reduce recurrence; may influence implantable cardioverter-defibrillator decision |
| Syncope with suspected arrhythmia | Inducibility of tachyarrhythmias; sinus node and atrioventricular node function | Guides pacemaker or defibrillator implantation |
Stepwise Investigation Algorithm
Practical Approach Based on Risk Stratification:
- All patients: 12-lead electrocardiogram, complete blood count, thyroid-stimulating hormone, electrolytes
- Low risk (benign history, normal electrocardiogram, no red flags): Reassurance; ambulatory monitoring only if symptoms frequent or troublesome
- Intermediate risk (infrequent symptoms, minor electrocardiogram abnormalities): Extended ambulatory monitoring; echocardiogram if structural heart disease suspected
- High risk (syncope, known heart disease, family history of sudden death, abnormal electrocardiogram): Echocardiogram, extended monitoring or implantable loop recorder, consider electrophysiology study, possibly cardiac MRI
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Palpitations with hemodynamic instability (hypotension, altered consciousness, chest pain, acute heart failure) | EMERGENT | Activate emergency response; obtain 12-lead electrocardiogram immediately; prepare for cardioversion if tachyarrhythmia; establish intravenous access |
| Palpitations with syncope or near-syncope | EMERGENT | Cardiac monitoring; 12-lead electrocardiogram; assess for ventricular tachycardia or high-grade atrioventricular block; echocardiogram; consider admission |
| Sustained palpitations (greater than 30 minutes) with rapid heart rate | URGENT | 12-lead electrocardiogram during symptoms; attempt vagal maneuvers if supraventricular tachycardia suspected; consider adenosine; rate or rhythm control |
| New-onset atrial fibrillation | URGENT | Rate control; assess stroke risk (CHA₂DS₂-VASc score); initiate anticoagulation if indicated; determine onset time for cardioversion planning |
| Palpitations with known structural heart disease or prior myocardial infarction | URGENT | 12-lead electrocardiogram; evaluate for ventricular arrhythmia; review ejection fraction; consider early cardiology consultation |
| Family history of sudden cardiac death with new palpitations | URGENT | 12-lead electrocardiogram (assess QT interval, pre-excitation, Brugada pattern); echocardiogram; cardiology referral; consider restricting exercise until evaluated |
| Intermittent palpitations without red flags, normal examination | ROUTINE | Baseline investigations (electrocardiogram, complete blood count, thyroid-stimulating hormone); ambulatory monitoring based on symptom frequency; reassurance if low risk |
| Palpitations clearly related to anxiety or caffeine, young patient, no cardiac history | ROUTINE | Baseline electrocardiogram to exclude pre-excitation or long QT; lifestyle modification; consider anxiety management; follow-up if symptoms persist |
Step 2: Risk Stratify the Patient
Low Risk
Features:
- Young patient (under 40 years)
- No structural heart disease
- Normal electrocardiogram
- No syncope or presyncope
- No family history of sudden death
- Symptoms consistent with ectopy or anxiety
Action: Reassurance; lifestyle modification; ambulatory monitoring only if symptoms troublesome
Intermediate Risk
Features:
- Age over 40 years
- Cardiovascular risk factors
- Minor electrocardiogram abnormalities
- Presyncope without syncope
- Frequent or prolonged episodes
- Exertional symptoms
Action: Extended ambulatory monitoring; echocardiogram; exercise testing if exertional; cardiology referral if arrhythmia documented
High Risk
Features:
- Known structural heart disease
- Reduced ejection fraction
- Prior myocardial infarction
- Syncope with palpitations
- Family history of sudden cardiac death
- Abnormal electrocardiogram (long QT, pre-excitation, Brugada)
Action: Expedited cardiology referral; comprehensive evaluation including echocardiogram, extended monitoring, possible electrophysiology study
Step 3: Follow Algorithm Based on Palpitation Character
Algorithm A: “Skipped Beats” or Irregular Palpitations
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Occasional skipped beats, pause then thump, otherwise well | Premature atrial or ventricular contractions | Reassurance; reduce caffeine and stress; Holter if frequent; echocardiogram if premature ventricular contraction burden high |
| Irregularly irregular rhythm on examination, variable pulse | Atrial fibrillation | Confirm with electrocardiogram; assess stroke risk; initiate rate control and anticoagulation as appropriate |
| Regular pattern of irregular beats (for example, every third beat feels different) | Bigeminy or trigeminy (premature atrial contractions or premature ventricular contractions) | Holter monitor to quantify; evaluate for underlying cause; beta-blocker if symptomatic |
Algorithm B: Rapid Regular Palpitations
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Gradual onset and offset; rate increases with activity and decreases with rest | Sinus tachycardia | Identify underlying cause (anxiety, fever, anemia, hyperthyroidism, hypovolemia); treat cause; rarely needs rate control alone |
| Sudden onset and offset (“like a switch”); rate 150-250 beats per minute; terminates with vagal maneuvers | Atrioventricular nodal re-entrant tachycardia or atrioventricular re-entrant tachycardia | Vagal maneuvers; adenosine 6mg then 12mg if no response; refer for electrophysiology study and ablation if recurrent |
| Rapid regular rate exactly 150 beats per minute | Atrial flutter with 2:1 conduction | Confirm with electrocardiogram (sawtooth flutter waves); rate control; consider cardioversion; anticoagulation; ablation referral |
| Rapid regular rhythm with hemodynamic compromise, wide QRS complexes | Ventricular tachycardia (or supraventricular tachycardia with aberrancy) | Treat as ventricular tachycardia until proven otherwise; synchronized cardioversion if unstable; amiodarone if stable; urgent cardiology consultation |
Algorithm C: Pounding or Forceful Palpitations at Normal Rate
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Pounding heart with anxiety, tremor, sweating; normal rate or mild tachycardia | Anxiety or panic disorder | Electrocardiogram to exclude arrhythmia; reassurance; address anxiety; consider selective serotonin reuptake inhibitors or cognitive behavioral therapy |
| Pounding with heat intolerance, weight loss, tremor | Hyperthyroidism | Check thyroid-stimulating hormone and free T4; beta-blocker for symptom control; refer to endocrinology |
| Pounding with fatigue, dyspnea on exertion, pallor | Anemia with hyperdynamic circulation | Complete blood count; reticulocyte count; iron studies; identify and treat cause of anemia |
| Pounding with bounding pulses and wide pulse pressure | Aortic regurgitation | Echocardiogram; cardiology referral; monitor for need for valve intervention |
| Pounding only when lying on left side or in quiet environments | Heightened awareness of normal heartbeat (somatization) | Electrocardiogram for reassurance; explain mechanism; address underlying anxiety if present |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient presents during active palpitations | Obtain 12-lead electrocardiogram immediately while symptomatic; assess vital signs and hemodynamic status | Treat based on rhythm; this is your best opportunity to diagnose the arrhythmia |
| Narrow-complex tachycardia, hemodynamically stable | Vagal maneuvers (carotid sinus massage, Valsalva, cold water to face); adenosine 6mg rapid intravenous push if vagal maneuvers fail | If adenosine terminates: likely atrioventricular nodal re-entrant tachycardia or atrioventricular re-entrant tachycardia; refer for electrophysiology study. If adenosine slows transiently: likely atrial fibrillation, flutter, or atrial tachycardia |
| Wide-complex tachycardia, hemodynamically stable | Treat as ventricular tachycardia; obtain expert consultation; consider amiodarone 150mg intravenous over 10 minutes | Cardiology consultation; echocardiogram; consider electrophysiology study; evaluate for implantable cardioverter-defibrillator |
| Any tachyarrhythmia with hemodynamic instability | Synchronized cardioversion (sedate if conscious); start at 100-200J for atrial fibrillation/flutter, 50-100J for supraventricular tachycardia, 100J for monomorphic ventricular tachycardia | Post-cardioversion care; identify and treat underlying cause; determine need for ongoing antiarrhythmic therapy or intervention |
| New atrial fibrillation, duration less than 48 hours | Rate control with beta-blocker or calcium channel blocker; assess bleeding and stroke risk; consider cardioversion | Calculate CHA₂DS₂-VASc score; initiate anticoagulation if indicated; determine rhythm versus rate control strategy |
| New atrial fibrillation, duration uncertain or greater than 48 hours | Rate control; initiate anticoagulation; do not cardiovert without adequate anticoagulation or transesophageal echocardiogram | Either 3 weeks of anticoagulation before cardioversion, or transesophageal echocardiogram to exclude thrombus followed by cardioversion |
| Pre-excitation (Wolff-Parkinson-White pattern) discovered on electrocardiogram | Avoid atrioventricular nodal blocking agents (adenosine, beta-blockers, calcium channel blockers, digoxin) if atrial fibrillation develops | Refer for electrophysiology study and ablation; counsel about risks of rapid atrial fibrillation; consider activity restrictions until ablation |
| Holter monitor shows frequent premature ventricular contractions (greater than 10% burden) | Obtain echocardiogram to assess left ventricular function | If ejection fraction reduced: consider ablation to prevent tachycardia-induced cardiomyopathy. If ejection fraction normal: reassurance, beta-blocker if symptomatic, repeat echocardiogram in 6-12 months |
| Prolonged QT interval discovered (QTc greater than 480 ms) | Review medications for QT-prolonging drugs; check potassium and magnesium; obtain family history | Remove offending drugs; correct electrolytes; if congenital long QT syndrome suspected, refer for genetic testing and consider beta-blocker therapy |
| Patient requests to “feel” their arrhythmia | Teach patient to check pulse during symptoms; consider smartphone or smartwatch electrocardiogram | Correlate patient-recorded events with formal monitoring; empowers patient and improves diagnostic yield |
Troubleshooting Refractory Palpitations
When Initial Workup Is Negative, Ask These Questions
- Was monitoring duration adequate? If symptoms are weekly, a 24-hour Holter will miss most episodes. Consider extended monitoring or implantable loop recorder.
- Did symptoms occur during monitoring? The key is symptom-rhythm correlation. Documented normal sinus rhythm during symptoms is reassuring.
- Were all reversible causes addressed? Recheck thyroid function, hemoglobin, electrolytes; reassess medication list; quantify caffeine and alcohol intake.
- Is anxiety contributing? Psychiatric comorbidity is present in up to 35% of patients with palpitations. Consider formal psychiatric evaluation if suspected.
- Is there an autonomic component? Consider postural orthostatic tachycardia syndrome or inappropriate sinus tachycardia if tachycardia is documented but standard workup is negative.
- Could multiple causes coexist? Patients may have both an arrhythmia and anxiety; treating one may not resolve all symptoms.
- Is electrophysiology study indicated? In patients with convincing paroxysmal symptoms, a negative non-invasive workup may warrant invasive evaluation, which may provoke the clinical arrhythmia.
When to Refer to Cardiology or Electrophysiology
| Referral Indication | Urgency | Expected Outcome |
|---|---|---|
| Documented sustained supraventricular tachycardia | Routine to urgent (weeks) | Electrophysiology study and ablation; cure rate greater than 95% |
| Atrial fibrillation or flutter for rhythm control consideration | Routine (weeks to months) | Cardioversion, antiarrhythmic therapy, or ablation planning |
| Wolff-Parkinson-White pattern on electrocardiogram | Urgent (days to weeks) | Risk stratification and ablation to prevent sudden death |
| Documented or suspected ventricular tachycardia | Urgent (days) | Risk stratification; implantable cardioverter-defibrillator evaluation; ablation consideration |
| Syncope with palpitations | Urgent (days) | Comprehensive evaluation; electrophysiology study if non-invasive workup inconclusive |
| Family history of sudden cardiac death with palpitations | Urgent (days to weeks) | Screening for inherited arrhythmia syndromes and cardiomyopathies |
| Frequent premature ventricular contractions with reduced ejection fraction | Routine to urgent | Ablation to improve left ventricular function |
| Palpitations refractory to initial management | Routine | Advanced monitoring; consideration of empiric electrophysiology study |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The rhythm strip during symptoms is gold: Make every effort to capture an electrocardiogram or rhythm strip while the patient is symptomatic. A documented rhythm during symptoms provides more diagnostic information than weeks of asymptomatic monitoring.
Ask patients to “tap out” the rhythm: Having patients tap on the desk or their leg to demonstrate the rhythm can help distinguish regular from irregular palpitations and estimate heart rate, providing valuable diagnostic clues before any testing.
Sudden onset and offset suggests re-entry: Palpitations that start and stop “like a switch” strongly suggest a re-entrant mechanism (atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia, or ventricular tachycardia) rather than sinus tachycardia, which accelerates and decelerates gradually.
Polyuria after episodes suggests supraventricular tachycardia: The release of atrial natriuretic peptide during sustained supraventricular tachycardia causes diuresis. Asking about increased urination after episodes can help identify supraventricular tachycardia even when no electrocardiogram is available.
A normal examination between episodes is expected: Many significant arrhythmias, including supraventricular tachycardia, paroxysmal atrial fibrillation, and even ventricular tachycardia in patients with structural heart disease, present with completely normal examinations between episodes. Do not be falsely reassured.
Match monitor duration to symptom frequency: A 24-hour Holter has only a 15-30% yield for infrequent palpitations. If symptoms occur weekly, use a 2-week event monitor. If monthly, consider an implantable loop recorder. Choosing the wrong monitor wastes time and resources.
Vagal maneuvers can be diagnostic and therapeutic: If a patient’s palpitations terminate with Valsalva or carotid massage, this strongly supports a diagnosis of atrioventricular nodal re-entrant tachycardia or atrioventricular re-entrant tachycardia and predicts excellent response to ablation.
Check the baseline electrocardiogram carefully: Pre-excitation (delta waves), prolonged QT interval, Brugada pattern, and epsilon waves are easily missed but have profound implications. Every patient with palpitations deserves a carefully analyzed resting electrocardiogram.
Critical Pitfalls to Avoid
Attributing palpitations to anxiety without adequate workup: While anxiety is common, it can coexist with genuine arrhythmias, and dismissing symptoms as “just anxiety” can delay diagnosis of serious conditions. Always obtain at least a baseline electrocardiogram and consider monitoring.
Using atrioventricular nodal blocking agents in Wolff-Parkinson-White with atrial fibrillation: Adenosine, beta-blockers, calcium channel blockers, and digoxin can accelerate conduction down the accessory pathway during atrial fibrillation, potentially causing ventricular fibrillation. Use procainamide or cardioversion instead.
Assuming wide-complex tachycardia is supraventricular tachycardia with aberrancy: In patients with structural heart disease, wide-complex tachycardia is ventricular tachycardia until proven otherwise. Treating ventricular tachycardia as supraventricular tachycardia can be fatal. When in doubt, treat as ventricular tachycardia.
Forgetting to ask about family history of sudden death: Inherited arrhythmia syndromes (long QT, Brugada, catecholaminergic polymorphic ventricular tachycardia) and cardiomyopathies may present first with palpitations. A family history of sudden death under age 50 demands thorough investigation.
Ignoring syncope associated with palpitations: Syncope during palpitations suggests hemodynamically significant arrhythmia, most concerning for ventricular tachycardia. This combination requires urgent evaluation and should never be managed as routine outpatient palpitations.
Cardioverting atrial fibrillation of uncertain duration without anticoagulation: Atrial fibrillation lasting more than 48 hours (or of uncertain duration) carries significant thromboembolic risk with cardioversion. Ensure 3 weeks of anticoagulation beforehand, or perform transesophageal echocardiogram to exclude left atrial thrombus.
Overlooking medications as a cause: Many common medications cause or exacerbate palpitations, including beta-agonists, decongestants, stimulants, and QT-prolonging drugs. Always perform a thorough medication review, including over-the-counter products and supplements.
Reassuring based on a single normal Holter: A 24-hour monitor that shows no arrhythmia while the patient is asymptomatic provides limited reassurance. The absence of symptoms during monitoring means the test was non-diagnostic, not normal. Extend monitoring or consider alternative approaches.
Key Takeaways
- Palpitations are extremely common, affecting up to 25% of the population, but only 15-20% have clinically significant cardiac arrhythmias requiring treatment.
- The primary diagnostic goal is symptom-rhythm correlation — documenting the heart rhythm during symptoms. Choose monitoring duration based on symptom frequency.
- A systematic approach using the “HEARTS” mnemonic ensures comprehensive history: How it feels, Episode details, Associated symptoms, Rate and rhythm, Triggers and timing, Stopping maneuvers.
- Red flags requiring urgent evaluation include syncope, known structural heart disease, family history of sudden cardiac death, and palpitations during exertion.
- Sudden onset and termination strongly suggests re-entrant tachycardia (supraventricular or ventricular), while gradual acceleration and deceleration suggests sinus tachycardia.
- A normal physical examination is common between episodes and does not exclude significant arrhythmia. The resting electrocardiogram may reveal pre-excitation, long QT, or other substrate for arrhythmia.
- Psychiatric causes (anxiety, panic disorder) account for approximately one-third of palpitation presentations and frequently coexist with cardiac arrhythmias.
- Risk stratify patients to guide investigation intensity: low-risk patients need reassurance and basic testing; high-risk patients need comprehensive evaluation including echocardiogram and extended monitoring.
- Supraventricular tachycardia (atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia) is highly curable with catheter ablation, with success rates exceeding 95%.
- Always consider reversible causes: thyroid dysfunction, anemia, electrolyte disturbances, caffeine, alcohol, and medications before attributing symptoms to primary arrhythmia.
Quick Reference Algorithm
Systematic Approach to Palpitations:
- Assess urgency: Is the patient hemodynamically stable? Is there syncope? Obtain electrocardiogram during symptoms if possible.
- Take focused history: Use “HEARTS” mnemonic. Identify red flags. Ask about sudden versus gradual onset, response to vagal maneuvers.
- Examine systematically: Vital signs (including orthostatics), cardiovascular examination, thyroid, signs of anemia or hyperthyroidism.
- Baseline investigations: 12-lead electrocardiogram, complete blood count, thyroid-stimulating hormone, electrolytes for all patients.
- Risk stratify: Determine low, intermediate, or high risk based on history, examination, and electrocardiogram findings.
- Select monitoring strategy: Match monitor duration to symptom frequency — daily symptoms: 24-48 hour Holter; weekly: 2-week monitor; monthly or less: implantable loop recorder.
- Echocardiogram if indicated: Obtain in patients with abnormal electrocardiogram, suspected structural heart disease, frequent premature ventricular contractions, or high-risk features.
- Refer appropriately: Electrophysiology referral for documented supraventricular tachycardia, Wolff-Parkinson-White syndrome, suspected ventricular tachycardia, or refractory symptoms.
- Address reversible factors: Treat thyroid dysfunction, correct anemia, replace electrolytes, reduce caffeine, discontinue offending medications.
- Reassess and follow up: If initial workup negative but symptoms persist, consider extended monitoring, electrophysiology study, or evaluation for psychiatric comorbidity.